Form D · Biotechnology
Stemgent, Inc.
Cambridge, MA · CIK 0001429173
Offering snapshot reported Aug 10, 2012 · SEC filing
- Reported sold
- $11.3M Offering amount: $11.3M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 4, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 10, 2012 | Initial | $11,299,993 | No comparison | 8 | SEC filing |
| Jan 31, 2012 | Initial | $6,297,998 | No comparison | 8 | SEC filing |
| Oct 28, 2011 | Initial | $584,810 | No comparison | 6 | SEC filing |
| Jun 10, 2011 | Amendment | $10,627,591 | $4,999,992vs May 13, 2010 | 8 | SEC filing |
| Apr 13, 2011 | Initial | $750,000 | No comparison | 8 | SEC filing |
| May 13, 2010 | Initial | $5,627,599 | No comparison | 6 | SEC filing |
| Nov 24, 2009 | Initial | $2,700,000 | No comparison | 2 | SEC filing |
| Jul 11, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 1, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 12, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 4, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-182570
Source: Form D, filed Aug 10, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ralph E. Christoffersen | Director |
| Augustine Lawlor | Director |
| Stefan Miltenyi | Director |
| Ian Ratcliffe | Director, Executive, Promoter |
| Harold R. Werner | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
One Kendall Square Suite B6201
Cambridge, MA, 02139
Cambridge, MA, 02139